Verrica Pharmaceuticals

$13.36 0.00% ($0.00)

Get ready to invest

About Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc. is a United States-based clinical-stage medical dermatology company. The Company is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The Company also intends to develop second cantharidin-based product candidate, VP-103, for the treatment of plantar warts. The Company has completed one Phase II clinical trial of topical solution of cantharidin administered with the wooden stick part of a cotton-tipped swab. It also conducting another Phase II clinical trial of topical solution of cantharidin administered through applicator, which collectively refer to as VP-102, for the treatment of molluscum.

Popular Stocks	Price	Change
Ford F	$15.7 0.44%	0.44%
Apple AAPL	$144.84 0.77%	0.77%
Bank of America BAC	$46.37 1.8%	1.8%
Wells Fargo WFC	$48.38 4.72%	4.72%
Virgin Galactic SPCE	$20.01 5.53%	5.53%
PG&E PCG	$11.2 2.28%	2.28%
Kosmos Energy KOS	$3.81 2.97%	2.97%
NIO NIO	$37.71 1.7%	1.7%
AMC AMC	$40.74 2.21%	2.21%